In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopenia

Blood

Volumn 91, Issue 1, 1998, Pages 353-359

  Ratajczak, Mariusz Z ^a,b   Ratajczak, Janina ^a   Machalinski, Boguslaw ^a   Mick, Rosemarie ^a   Gewirtz, Alan M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPENIA;

EID: 0031975145     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.353.353_353_359     Document Type: Article

References (33)

1. Hogge DE, McConnell M, Jacobson C, Sutherland HJ, Benny WB, Massing BG: Platelet refractioness and alloimmunization in pediatric oncology and bone marrow transplant patients. Transfusion 35:645, 1995
2. Rintels PB, Kenny RM, Crowley JP: Therapeutic support of the patients with thrombocytopenia. Hematol Oncol Clin North Am 8:1131, 1994
3. Hassan HT, Zander A: Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: An unresolved problem and possible approaches to resolve it. J Hematother 5:407, 1996
4. Anderlini P, Korbling M: The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem Cells 15:9, 1997
5. Gordon MS, Nemunaitis J, Hoffman R, Paquette RL, Rosenfield C, Manfreda S, Isaacs R, Nimer SD: A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood 85:3066, 1995
6. Nand S, Sosman J, Godwin JE, Fisher RI: A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony stimulating factor in myelodysplastic syndromes. Blood 83:357, 1994
7. Vial T, Descotes J: Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Saf 13:357, 1995
8. Hussein A, Fisher D, Vredenburgh J, Rubin P, Elkorky M, Peters W, Peret N, Dykstra K, Kaye JA: Phase 2 trial of Neumega rhIl-11 in patients with breast cancer after high-dose chemotherapy with bone marrow and peripheral blood stem cell support. Blood 88:300a, 1996 (abstr, suppl 1)
9. Fibbe WE, Heemskerk DPM, Laterveer L, Pruijt JFM, Foster D, Kaushansky K, Willemze R: Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 86:3308, 1995
10. Gewirtz AM, Calabretta B, Rucinski B, Niewiarowski S, Xu WY: Inhibition of human megakaryopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 83:1477, 1989
11. Mitjavila MT, Vinci G, Villeval JL, Kieffer N, Henri A, Testa U, Breston-Gorias J, Vainchenker W: Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: Its relationship to type beta transforming growth factor (TGF-beta). J Cell Physiol 134:93, 1988
12. Wickenhauser C, Hillienhoff A, Jungheim K, Lorenzen J, Ruskowski H, Hansmann ML, Thiele J, Fisher R: Detection and quantification of transforming growth factor beta (TGF-beta) and platelet derived growth factor (PDGF) release by normal human megakaryocytes. Leukemia 9:310, 1995
13. Gewirtz AM: Megakaryocytopoiesis: The state of the art. thromb Hemost 74:204, 1995
14. Ratajczak MZ, Luger SM, DeRiel K, Abrahm J, Calabretta B, Gewirtz AM: Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 89:1710, 1992
15. Ratajczak MZ, Ratajczak J, Kregenow DA, Gewirtz AM: Growth factor stimulation of cryopreserved CD34+ bone marrow cells intended for transplant: An in vitro study to determine optimal timing of exposure to early acting cytokines. Stem Cells 12:599, 1994
16. Ratajczak MZ, Ratajczak J, Kregenow DA, Kuczynski WI, Skorski T, Gewirtz AM: Cytokine stimulation of CD34+ bone marrow cells prior to cryopreservation enhances their post-thawing proliferative potential. Folia Histochem Cytobiol 32:149, 1993
17. Ratajczak MZ, Ratajczak J, Skorska M, Marlicz W, Calabretta B, Pletcher CH, Moore J, Gewirtz AM: Effect of basic (FGF-2) and acidic (FGF-1) fibroblast growth factors on early haematopoietic cell development. Br J Haematol 93:772, 1996
18. Jedrzejczak WW, Pojda Z, Ahmed A, Ratajczak MZ: Hematological compensation of microphthalmic mice with congenital osteopetrosis. Bone 8:315, 1987
19. Gewirtz AM: Developmental biology of megakaryocytes and platelets, in Adamson JW (ed): Current Opinion in Hematology. New York, NY, Current Science, 1993, p 256
20. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with: 11-3,11-6, H-11, and SCF acquire an engraftment defect in normal host. Exp Hematol 23:461, 1995
21. Yonemura Y, Ku H, Hirayama F, Souza LM, Ogawa M: Interleukin 3 or interleukin 1 abrogates the reconstitution ability of hematopoietic stem cells. Proc Natl Acad Sci USA 93:4040, 1996
22. van der Loo JCM, Ploemacher RE: Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 85:2598, 1995
23. Spangrude GJ, Brooks DM, Tumas DB: Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 85:1006, 1995
24. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11 and stem cell factor leads to impaired engraftment in irradiated host. Blood 87:30, 1996
25. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827, 1994
26. Frampton JE, Lee CR, Faulds D: Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48:731, 1994
27. Rapoport AP, Abboud CN, BiPersio JF: Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor biology, signal transduction, and neutrophil activation. Blood Rev 6:43, 1992
28. Naparstek E, Hardan Y, Ben-Shahar M, Nagler A, Or R, Mumcuoglu M, Weiss L, Samuel S, Slavin S: Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte macrophage colony-stimulating factor. Blood 80:1673, 1992
29. Atkinson K, Bartlett A, Dodds A, Railings M: Lack of efficacy of a short ex vivo incubation of human allogeneic donor marrow with recombinant human GM-CSF prior to its infusion into the recipient. Bone Marrow Transplant 14:573, 1994
30. Kovach NL, Lin N, Vednock T, Harlan JM, Broudy VC: Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood 85:159, 1995
31. Lebkowski JS, Schain L, Okarma TB: Serum-free culture of hematopoietic stem cells: A review. Stem Cells 13:607, 1995
32. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
33. Lansdorp PM, Dragowska W: Long-term erythropoiesis from constant numbers of CD34+ cells iri serum-free cultures initiated with highly purified progenitor cells from human bone marrow. J Exp Med 175:1501, 1992